Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Finding the intended use population for a new treatment.

Simon R, Simon N.

J Biopharm Stat. 2019;29(4):675-684. doi: 10.1080/10543406.2019.1636812. Epub 2019 Jul 15.

PMID:
31304851
2.

Clinical trials for predictive medicine: new challenges and paradigms.

Simon R.

Clin Trials. 2010 Oct;7(5):516-24. doi: 10.1177/1740774510366454. Epub 2010 Mar 25.

3.

Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.

4.

Drug-diagnostics co-development in oncology.

Simon R.

Front Oncol. 2013 Dec 23;3:315. doi: 10.3389/fonc.2013.00315. Review.

5.

Clinical trials for predictive medicine.

Simon R.

Stat Med. 2012 Nov 10;31(25):3031-40. doi: 10.1002/sim.5401. Epub 2012 Jun 19.

PMID:
22714719
6.

On the efficiency of targeted clinical trials.

Maitournam A, Simon R.

Stat Med. 2005 Feb 15;24(3):329-39.

PMID:
15551403
7.

Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.

Basu S, Sussman JB, Rigdon J, Steimle L, Denton BT, Hayward RA.

PLoS Med. 2017 Oct 17;14(10):e1002410. doi: 10.1371/journal.pmed.1002410. eCollection 2017 Oct.

8.

The project data sphere initiative: accelerating cancer research by sharing data.

Green AK, Reeder-Hayes KE, Corty RW, Basch E, Milowsky MI, Dusetzina SB, Bennett AV, Wood WA.

Oncologist. 2015 May;20(5):464-e20. doi: 10.1634/theoncologist.2014-0431. Epub 2015 Apr 15.

9.

Use of genomic signatures in therapeutics development in oncology and other diseases.

Simon R, Wang SJ.

Pharmacogenomics J. 2006 May-Jun;6(3):166-73.

PMID:
16415922
10.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
11.
12.

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.

Le Tourneau C, Delord JP, Gonçalves A, Gavoille C, Dubot C, Isambert N, Campone M, Trédan O, Massiani MA, Mauborgne C, Armanet S, Servant N, Bièche I, Bernard V, Gentien D, Jezequel P, Attignon V, Boyault S, Vincent-Salomon A, Servois V, Sablin MP, Kamal M, Paoletti X; SHIVA investigators.

Lancet Oncol. 2015 Oct;16(13):1324-34. doi: 10.1016/S1470-2045(15)00188-6. Epub 2015 Sep 3.

PMID:
26342236
13.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

PMID:
12869717
14.

Different ways to describe the benefits of risk-reducing treatments: a randomized trial.

Halvorsen PA, Selmer R, Kristiansen IS.

Ann Intern Med. 2007 Jun 19;146(12):848-56.

PMID:
17577004
15.

Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Melnikow J, Henderson JT, Burda BU, Senger CA, Durbin S, Soulsby MA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Aug.

16.

Developing and validating continuous genomic signatures in randomized clinical trials for predictive medicine.

Matsui S, Simon R, Qu P, Shaughnessy JD Jr, Barlogie B, Crowley J.

Clin Cancer Res. 2012 Nov 1;18(21):6065-73. doi: 10.1158/1078-0432.CCR-12-1206. Epub 2012 Aug 27.

17.

Screening for Chronic Obstructive Pulmonary Disease: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Guirguis-Blake JM, Senger CA, Webber EM, Mularski R, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Apr.

18.

Tuberculosis.

Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P.

In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11.

19.

Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.

Dearfield KL, Gollapudi BB, Bemis JC, Benz RD, Douglas GR, Elespuru RK, Johnson GE, Kirkland DJ, LeBaron MJ, Li AP, Marchetti F, Pottenger LH, Rorije E, Tanir JY, Thybaud V, van Benthem J, Yauk CL, Zeiger E, Luijten M.

Environ Mol Mutagen. 2017 Jun;58(5):264-283. doi: 10.1002/em.22045. Epub 2016 Sep 21. Review.

PMID:
27650663
20.

Evaluation of the Benefits and Harms of Aspirin for Primary Prevention of Cardiovascular Events: A Comparison of Quantitative Approaches [Internet].

Puhan MA, Singh S, Weiss CO, Varadhan R, Sharma R, Boyd CM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov.

Supplemental Content

Support Center